Consumer health value sales will continue to grow in 2020, despite the negative economic impact of COVID-19 on the economy. Lower purchasing power among middle-income consumers and the rising cost of healthcare in Argentina have fuelled a shift towards self-medication in recent years, thus encouraging preventive healthcare. Following this...
The outbreak of COVID-19 in South Korea is not predicted to increase growth in 2020, with value growth of 3% expected for the year, compared to value growth of 5% recorded in 2019. As South Korea did not have an enforced lockdown, sales were not impacted by high levels of stockpiling that was seen in other countries Consumer Health...
The outbreak of COVID-19 is not expected to increase growth in 2020, with value growth of 2% predicted for the year, compared to value growth of 4% recorded in 2019. Unlike other countries, Sweden did not go into a full lockdown during Q1 and Q2, and this had some impact on the level of stockpiling that took place, which was mainly seen in...
The consumer health market in Singapore recorded a positive performance in 2020, with the outbreak of the COVID-19 pandemic contributing to overall growth. Across the industry, it is clear that some categories outperformed others, namely systemic analgesics, cough, cold remedies and immunity boosting vitamins and dietary supplements, as consumers...
The categories expected to see the biggest surge in demand in 2020 because of COVID-19 include products aimed at supporting consumers’ immune systems, such as vitamins, dietary supplements, and herbal/traditional products. These categories experienced significant stockpiling as consumers panic bought products to ensure the health of their...
2020 has proven to be a fairly turbulent year for consumer health in Germany following the emergence of the pandemic. After the ‘’hamster’’ (stockpiling purchases) period in March due to various lockdown restrictions by the government in an effort to curb the spread of the virus, it was followed by a slump, with the market subsequently entering...
The outbreak of COVID-19 is not set to increase growth in 2020, with value growth of 3% predicted, compared to value growth of 4% recorded in 2019. Unlike other countries within Western Europe, there was not a high level of stockpiling reported for consumer health products in Norway. However, adult acetaminophen was one area which recorded...
The Malaysian Government implemented the Movement Control Order (MCO) from 18 March to 4 May in an effort to contain the spread of the COVID-19 pandemic in the country. There followed the Conditional Movement Control Order (CMCO) – between 4 May and 10 June, and the Recovery Movement Control Order (RMCO) – between 10 June and 31 August. All...
Overall, consumer health is expected to perform well, due to increased demand as a result of COVID-19, with most areas product areas expected to register double-digit current value growth. Though 2020 current value growth is not expected to be as high as in 2019, a lot of the growth over the review period was driven by inflation rather than...
The outbreak and development of Coronavirus (COVID-19) from early March 2020 halted the economic improvement in the country. Lockdown and other restrictions on business, education and cultural institutions and the population in general fed into rising unemployment, wage cuts and reduced disposable incomes as the government tried to contain...